Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
MT

WKN: A42B3C | ISIN: CNE100007LD1 | Ticker: RO9
Frankfurt
20.11.26 | 15:25
0,753 Euro
-9,83 % -0,082
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
METIS TECHBIO CO LTD Chart 1 Jahr
5-Tage-Chart
METIS TECHBIO CO LTD 5-Tage-Chart

Aktuelle News zur METIS TECHBIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
METIS TECHBIO Aktie jetzt für 0€ handeln
FrMETIS TECHBIO-P Plans On-mkt Share Buyback2
FrMETIS TECHBIO-P (07666): VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE REPURCHASE UNDER GENERAL MANDATE1
FrMetis TechBio plans A-share listing1
MiMETIS TECHBIO-P Proposes A-Share Listing Plan2
MiMETIS TECHBIO-P (07666): INSIDE INFORMATION PROPOSED A SHARE LISTING PLAN3
19.10.METIS TECHBIO-P (07666): VOLUNTARY ANNOUNCEMENT METIS TECHBIO ENTERED STRATEGIC COLLABORATION WITH LILLY TO ADVANCE NEXT-GENERATION TISSUE-SPECIFIC LNP ...2
29.09.METIS TECHBIO-P (07666): 2026 INTERIM REPORT4
04.09.METiS TechBio revenue surges on licensing deal2
25.08.METIS TECHBIO-P (07666): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026-
12.08.METIS TECHBIO-P (07666): DATE OF BOARD MEETING1
04.08.METIS TECHBIO-P (07666): (1) APPOINTMENT OF JOINT COMPANY SECRETARY; AND (2) WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES-
03.08.METIS TECHBIO-P (07666): VOLUNTARY ANNOUNCEMENT METIS TECHBIO ANNOUNCES COLLABORATION WITH HENGRUI PHARMACEUTICALS ON THE AITEM ARTIFICIAL INTELLIGENCE ...2
31.07.METIS TECHBIO-P (07666): (1) RESIGNATION OF CHIEF FINANCIAL OFFICER, BOARD SECRETARY AND JOINT COMPANY SECRETARY AND CHANGE OF PROCESS AGENT; (2) CHANGE ...2
30.06.Deerfield's Boulevard Bio pens $1.6B deal for trispecific TCE from China's Metis TechBio2
30.06.Metis TechBio seals $1.62b global licensing deal with Boulevard Bio1
30.06.METiS TechBio vergibt Lizenz für Wirkstoffkandidaten in 1,6-Milliarden-Dollar-Deal-
30.06.METiS TechBio licenses drug candidate to Boulevard Bio for $1.6B3
30.06.METIS TECHBIO-P (07666): VOLUNTARY ANNOUNCEMENT METIS TECHBIO ANNOUNCES A PRECLINICAL TCE LICENSING COLLABORATION WITH DEERFIELD OF UP TO US$1.6 BILLION2
22.06.METIS TECHBIO-P (07666): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS OF AND REQUEST FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS-
22.06.METIS TECHBIO-P (07666): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS1
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1